136 related articles for article (PubMed ID: 11821630)
1. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Tepper D
Congest Heart Fail; 2002; 8(1):57-8. PubMed ID: 11821630
[No Abstract] [Full Text] [Related]
2. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Hollenberg NK
Curr Hypertens Rep; 2002 Dec; 4(6):411; discussion 412. PubMed ID: 12462208
[No Abstract] [Full Text] [Related]
3. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
Cohn JN; Tognoni G;
N Engl J Med; 2001 Dec; 345(23):1667-75. PubMed ID: 11759645
[TBL] [Abstract][Full Text] [Related]
4. Valsartan in chronic heart failure.
Campbell DJ
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951863
[No Abstract] [Full Text] [Related]
5. Valsartan in chronic heart failure.
Forfar JC; Munir S
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951862
[No Abstract] [Full Text] [Related]
6. Are angiotensin II receptor antagonists indicated in chronic heart failure?
Komajda M
Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
[TBL] [Abstract][Full Text] [Related]
7. Valsartan in chronic heart failure.
Haddy FJ
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11948282
[No Abstract] [Full Text] [Related]
8. [Sartan as a new therapy option. When heart failure patients cannot tolerate an ACE inhibitor].
MMW Fortschr Med; 2002 Oct; 144(40):49. PubMed ID: 12440300
[No Abstract] [Full Text] [Related]
9. Valsartan in chronic heart failure.
Cayley WE
N Engl J Med; 2002 Apr; 346(15):1173-4. PubMed ID: 11951861
[No Abstract] [Full Text] [Related]
10. [Heart failure. With the AT1-blocker less frequent rehospitalization].
MMW Fortschr Med; 2001 May; 143(20):65. PubMed ID: 11400619
[No Abstract] [Full Text] [Related]
11. Anti-angiotensin therapy: new perspectives.
Ramasubbu K; Mann DL; Deswal A
Cardiol Clin; 2007 Nov; 25(4):573-80; vi-vii. PubMed ID: 18063161
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
13. Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.
Krum H; Carson P; Farsang C; Maggioni AP; Glazer RD; Aknay N; Chiang YT; Cohn JN
Eur J Heart Fail; 2004 Dec; 6(7):937-45. PubMed ID: 15556056
[TBL] [Abstract][Full Text] [Related]
14. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
15. Valsartan in chronic heart failure.
Ripley TL
Ann Pharmacother; 2005 Mar; 39(3):460-9. PubMed ID: 15687480
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockers and congestive heart failure.
Auer JW; Berent R; Eber B
Circulation; 2001 Oct; 104(15):E82. PubMed ID: 11591633
[No Abstract] [Full Text] [Related]
17. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
[TBL] [Abstract][Full Text] [Related]
18. Lessons learned from the valsartan- heart failure trial (Val-HeFT): angiotensin receptor blockers in heart failure.
Cohn JN
Am J Cardiol; 2002 Nov; 90(9):992-3. PubMed ID: 12398968
[No Abstract] [Full Text] [Related]
19. [Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
MMW Fortschr Med; 2003 Oct; 145(43):51. PubMed ID: 14664222
[No Abstract] [Full Text] [Related]
20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
